Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis

NCT05920018 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DIETARY_SUPPLEMENT: Vivomixx®
DIETARY_SUPPLEMENT: Conjugated linoleic acid (CLA/Tonalin® FFA 80)
OTHER: Maltose placebo
OTHER: Sunflower oil placebo

Sponsor

Universität Münster